Live Breaking News & Updates on Mbrace Therapeutics Inc
Stay updated with breaking news from Mbrace therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lead investigational candidate, MBRC-101, uniquely targets EphA5 receptor tyrosine kinase, which is present in multiple cancers, including breast, non-small cell lung (NSCLC), colorectal, gastric, and pancreatic cancersNew data support potential of MBRC-101 for treatment of solid tumors including hormone receptor-po. ....